G42 Healthcare: #4Humanity – Launching the World’s First Phase III Clinical Trial for an Inactivated COVID-19 Vaccine

G42 Healthcare, a health-tech company, launched its #4Humanity campaign to drive volunteers for the world's first phrase three clinical trial for an inactivated COVID-19 vaccine in the Middle East.

Summary

To support the global community in its fight against the ongoing COVID-19 pandemic, G42 Healthcare commenced the world's first phase III clinical trial of an inactivated COVID-19 vaccine in July 2020. The phase III clinical trial considers the safety in the UAE alone. With only a few days from concept development to launch, G42 Healthcare and APCO mobilized their efforts across communications, media relations, crisis management, digital, social media, campaign identity, and on-ground branding to prepare for the launch and welcome the first volunteers.

WARC subscribers can sign in to keep reading

Not a subscriber?

WARC helps you to plan, create and deliver more effective marketing

  • Prove your case and back-up your idea

  • Get expert guidance on strategic challenges

  • Tackle current and emerging marketing themes

Learn more Get a demo

WARC consistently delivers valuable insights that help to make me look like an expert in front of my colleagues and clients.

Dasha Boryso
Strategy Partner, Fetch

You’re in good company

We work with 80% of Forbes' most valuable brands* and 80% of the world's top top-of-the-class agencies.

* Top 10 brands